Skin·3 min read

This experimental “super vaccine” stopped cancer cold in the lab

By InsideWellness Editorial · October 13, 2025

Originally published by ScienceDaily Skin Care.

UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, pancreatic, and triple-negative breast cancers in mice—with up to 88% remaining tumor-free. The vaccine triggers a multi-pathway immune response, producing powerful T-cell activation and long-term immune

Read the full article on ScienceDaily Skin Care →

This summary appears courtesy of ScienceDaily Skin Care. Read the full article on ScienceDaily Skin Care →

About the author

InsideWellness Editorial

Our editorial team curates and writes on wellness research, beauty science, and evidence-backed lifestyle insights. See our editorial standards for how we source and review content.

More to read

Stay informed

Join our weekly digest of evidence-backed wellness research.